Patents by Inventor Jennifer Lynne Nolen

Jennifer Lynne Nolen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9044722
    Abstract: A tissue filling, repair, sealing, or bonding substance comprising at least three components, at least two of which upon coming into fluid communication with each other react and change the chemical, structural or other properties of the substance so as to bond to adjacent native or implanted tissue. The composition is further defined as comprising a first component of a curable substance, a second component of a suitable curing agent, and a third component of an encapsulant capable of forming a barrier between the first two components and physically arranged to form an encapsulated dispersion of the form interior phase (linking agent), exterior phase (encapsulant), and continuous phase (curable substance). The encapsulant is further defined as having limited solubility in the curable substance and the curing agent and having a melting temperature between 10° C.-50° C.
    Type: Grant
    Filed: November 10, 2011
    Date of Patent: June 2, 2015
    Inventors: Darren Edward Nolen, Jennifer Lynne Nolen
  • Publication number: 20120111229
    Abstract: A tissue filling, repair, sealing, or bonding substance comprising at least three components, at least two of which upon coming into fluid communication with each other react and change the chemical, structural or other properties of the substance so as to bond to adjacent native or implanted tissue. The composition is further defined as comprising a first component of a curable substance, a second component of a suitable curing agent, and a third component of an encapsulant capable of forming a barrier between the first two components and physically arranged to form an encapsulated dispersion of the form interior phase (linking agent), exterior phase (encapsulant), and continuous phase (curable substance). The encapsulant is further defined as having limited solubility in the curable substance and the curing agent and having a melting temperature between 10° C.-50° C.
    Type: Application
    Filed: November 10, 2011
    Publication date: May 10, 2012
    Inventors: Darren Edward Nolen, Jennifer Lynne Nolen